| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.791 | 0.003 | 0.791 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.777 | 0.003 | 0.777 | Raf kinase inhibitor | |||
| 0.748 | 0.001 | 0.748 | Raf kinase C inhibitor | 0.401 0.004 DBMET00675 | ||
| 0.734 | 0.003 | 0.734 | Raf kinase B inhibitor | |||
| 0.596 | 0.006 | 0.596 | Calcium channel L-type activator | 0.565 0.01 DBMET00675 | ||
| 0.436 | 0.005 | 0.436 | TIE antagonist | |||
| 0.44 | 0.018 | 0.44 | Antimitotic | 0.283 0.049 DBMET00675 | ||
| 0.423 | 0.005 | 0.423 | TIE-2 antagonist | |||
| 0.388 | 0.029 | 0.444 | Calcium channel activator | 0.444 0.012 DBMET00675 | DBMET00675 | |
| 0.406 | 0.052 | 0.406 | Angiogenesis inhibitor | |||
| 0.374 | 0.02 | 0.374 | EphB2 antagonist | |||
| 0.344 | 0.004 | 0.44 | Potassium channel (Ca-activated) blocker | 0.44 0.003 DBMET00675 | DBMET00675 | |
| 0.328 | 0.016 | 0.328 | Tubulin antagonist | 0.169 0.05 DBMET00675 | ||
| 0.342 | 0.048 | 0.342 | Hypoxia-inducible factor 1 alpha inhibitor | 0.242 0.108 DBMET00675 | ||
| 0.276 | 0.005 | 0.276 | Hedgehog signaling inhibitor | |||
| 0.261 | 0.008 | 0.261 | Catalase inhibitor | 0.087 0.044 DBMET00675 | ||
| 0.249 | 0.009 | 0.249 | Microtubule formation inhibitor | 0.119 0.061 DBMET00675 | ||
| 0.277 | 0.042 | 0.277 | Platelet aggregation inhibitor | 0.154 0.124 DBMET00675 | ||
| 0.241 | 0.007 | 0.241 | Gastric antisecretory | 0.092 0.075 DBMET00675 | ||
| 0.229 | 0.012 | 0.311 | Check point kinase 2 inhibitor | 0.311 0.006 DBMET00675 | DBMET00675 | |
| 0.278 | 0.073 | 0.372 | Insulysin inhibitor | 0.372 0.027 DBMET00675 | DBMET00675 | |
| 0.347 | 0.148 | 0.347 | Caspase 9 stimulant | 0.332 0.161 DBMET00675 | ||
| 0.289 | 0.097 | 0.315 | Vasodilator, coronary | 0.315 0.076 DBMET00675 | DBMET00675 | |
| 0.217 | 0.026 | 0.217 | ATPase inhibitor | 0.162 0.082 DBMET00675 | ||
| 0.214 | 0.023 | 0.214 | Platelet activating factor antagonist | |||
| 0.29 | 0.1 | 0.29 | Transcription factor NF kappa B inhibitor | |||
| 0.2 | 0.016 | 0.2 | Platelet activating factor alpha antagonist | |||
| 0.189 | 0.014 | 0.267 | HIV-1 integrase (Overall Integration) inhibitor | 0.267 0.004 DBMET00675 | DBMET00675 | |
| 0.211 | 0.037 | 0.211 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.203 0.041 DBMET00675 | ||
| 0.144 | 0.006 | 0.144 | Granulocyte macrophage colony stimulating factor agonist | 0.137 0.008 DBMET00675 | ||
| 0.133 | 0.006 | 0.133 | Potassium channel (ATP-sensitive) blocker | 0.109 0.012 DBMET00675 | ||
| 0.156 | 0.036 | 0.156 | Interleukin 1b antagonist | 0.15 0.04 DBMET00675 | ||
| 0.173 | 0.054 | 0.173 | NOS3 expression enhancer | |||
| 0.186 | 0.072 | 0.186 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.131 | 0.019 | 0.131 | mTOR complex 1 inhibitor | |||
| 0.12 | 0.013 | 0.12 | DNA gyrase inhibitor | |||
| 0.166 | 0.059 | 0.166 | Protein kinase (CK1) gamma inhibitor | 0.112 0.099 DBMET00675 | ||
| 0.122 | 0.019 | 0.122 | Prostaglandin-E synthase inhibitor | 0.07 0.049 DBMET00675 | ||
| 0.237 | 0.135 | 0.237 | Cholesterol antagonist | 0.217 0.15 DBMET00675 | ||
| 0.16 | 0.06 | 0.16 | Lck kinase inhibitor | |||
| 0.154 | 0.054 | 0.187 | MAP kinase kinase 4 inhibitor | 0.187 0.019 DBMET00675 | DBMET00675 | |
| 0.102 | 0.005 | 0.102 | Factor XIa inhibitor | |||
| 0.118 | 0.023 | 0.118 | Glutamate release inhibitor | 0.101 0.041 DBMET00675 | ||
| 0.149 | 0.058 | 0.149 | Interleukin 1 antagonist | 0.129 0.077 DBMET00675 | ||
| 0.148 | 0.058 | 0.148 | Pregnane X receptor agonist | 0.147 0.059 DBMET00675 | ||
| 0.204 | 0.115 | 0.204 | Cardiotonic | |||
| 0.177 | 0.09 | 0.177 | Growth factor agonist | |||
| 0.141 | 0.054 | 0.141 | Antibacterial (Helicobacter pylori) | 0.109 0.1 DBMET00675 | ||
| 0.133 | 0.05 | 0.133 | DNA repair enzyme inhibitor | |||
| 0.129 | 0.046 | 0.161 | Protein kinase C gamma inhibitor | 0.161 0.026 DBMET00675 | DBMET00675 | |
| 0.141 | 0.058 | 0.141 | Protein kinase (CK1) delta inhibitor | |||
| 0.107 | 0.028 | 0.107 | Histamine H2 receptor antagonist | 0.094 0.041 DBMET00675 | ||
| 0.09 | 0.013 | 0.124 | Factor IXa inhibitor | 0.124 0.005 DBMET00675 | DBMET00675 | |
| 0.113 | 0.037 | 0.119 | Potassium channel activator | 0.119 0.033 DBMET00675 | DBMET00675 | |
| 0.136 | 0.06 | 0.136 | Vascular endothelial growth factor antagonist | |||
| 0.185 | 0.111 | 0.26 | Aryl hydrocarbon receptor agonist | 0.26 0.075 DBMET00675 | DBMET00675 | |
| 0.092 | 0.018 | 0.092 | CDK4/cyclin D1 inhibitor | |||
| 0.159 | 0.089 | 0.159 | LIM domain kinase 1 inhibitor | |||
| 0.123 | 0.053 | 0.135 | Photosensitizer | 0.135 0.042 DBMET00675 | DBMET00675 | |
| 0.173 | 0.103 | 0.173 | Insulin sensitizer | 0.173 0.104 DBMET00675 | ||
| 0.125 | 0.058 | 0.125 | Vascular endothelial growth factor 2 antagonist | |||
| 0.109 | 0.046 | 0.109 | CDK/cyclin complex inhibitor | |||
| 0.067 | 0.005 | 0.067 | Factor XI inhibitor | |||
| 0.077 | 0.023 | 0.077 | CDK4/cyclin D inhibitor | |||
| 0.096 | 0.044 | 0.096 | Platelet growth factor antagonist | 0.077 0.06 DBMET00675 | ||
| 0.181 | 0.131 | 0.232 | RNA-directed DNA polymerase inhibitor | 0.232 0.063 DBMET00675 | DBMET00675 | |
| 0.053 | 0.004 | 0.053 | HCV NS5A inhibitor | |||
| 0.114 | 0.066 | 0.114 | Protein kinase (CK2) alpha inhibitor | |||
| 0.283 | 0.236 | 0.397 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.397 0.103 DBMET00675 | DBMET00675 | |
| 0.073 | 0.027 | 0.073 | Transcription factor AP-1 inhibitor | |||
| 0.069 | 0.024 | 0.069 | Alpha tubulin antagonist | |||
| 0.147 | 0.104 | 0.147 | Tumour necrosis factor antagonist | |||
| 0.07 | 0.028 | 0.086 | Cyclin D1 inhibitor | 0.086 0.014 DBMET00675 | DBMET00675 | |
| 0.098 | 0.057 | 0.098 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.1 | 0.063 | 0.1 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.124 | 0.088 | 0.124 | Protein kinase (CK1) inhibitor | |||
| 0.109 | 0.075 | 0.109 | Protein kinase (CK1) gamma 2 inhibitor | 0.098 0.086 DBMET00675 | ||
| 0.036 | 0.005 | 0.036 | Acid ceramidase inhibitor | 0.031 0.008 DBMET00675 | ||
| 0.148 | 0.117 | 0.245 | Pyruvate kinase inhibitor | 0.245 0.062 DBMET00675 | DBMET00675 | |
| 0.135 | 0.107 | 0.135 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.108 | 0.08 | 0.108 | Interleukin 8 antagonist | 0.1 0.096 DBMET00675 | ||
| 0.03 | 0.003 | 0.031 | Granulocyte colony stimulating factor receptor agonist | 0.031 0.003 DBMET00675 | DBMET00675 | |
| 0.12 | 0.095 | 0.12 | CDC-like kinase 1 inhibitor | |||
| 0.157 | 0.133 | 0.56 | Aldehyde oxidase inhibitor | 0.56 0.024 DBMET00675 | DBMET00675 | |
| 0.062 | 0.039 | 0.062 | Beta tubulin antagonist | |||
| 0.227 | 0.204 | 0.227 | Transcription factor inhibitor | |||
| 0.048 | 0.026 | 0.087 | Potassium channel small-conductance Ca-activated blocker | 0.087 0.008 DBMET00675 | DBMET00675 | |
| 0.115 | 0.093 | 0.115 | Interleukin 4 antagonist | |||
| 0.033 | 0.015 | 0.04 | Elastase 2B inhibitor | 0.04 0.008 DBMET00675 | DBMET00675 | |
| 0.033 | 0.015 | 0.04 | Elastase 3A inhibitor | 0.04 0.008 DBMET00675 | DBMET00675 | |
| 0.033 | 0.015 | 0.04 | Elastase 3B inhibitor | 0.04 0.008 DBMET00675 | DBMET00675 | |
| 0.06 | 0.044 | 0.06 | Cyclin B1 inhibitor | |||
| 0.099 | 0.083 | 0.099 | CDC-like kinase 3 inhibitor | |||
| 0.106 | 0.09 | 0.115 | MAP kinase 12 inhibitor | 0.115 0.076 DBMET00675 | DBMET00675 | |
| 0.05 | 0.035 | 0.093 | Potassium channel (Inward rectifier) activator | 0.093 0.005 DBMET00675 | DBMET00675 | |
| 0.143 | 0.128 | 0.143 | P-glycoprotein inhibitor | |||
| 0.054 | 0.04 | 0.054 | Cyclin B2 inhibitor | 0.052 0.044 DBMET00675 | ||
| 0.048 | 0.034 | 0.09 | Potassium channel (ATP-sensitive) activator | 0.09 0.005 DBMET00675 | DBMET00675 | |
| 0.112 | 0.098 | 0.112 | Cytokine production inhibitor | |||
| 0.083 | 0.071 | 0.083 | ATPase (Vacuolar H+) inhibitor | |||
| 0.141 | 0.13 | 0.155 | I kappa B kinase epsilon inhibitor | 0.155 0.115 DBMET00675 | DBMET00675 | |
| 0.079 | 0.067 | 0.079 | Stem cell growth factor agonist | |||
| 0.075 | 0.064 | 0.08 | MAP kinase kinase 7 inhibitor | 0.08 0.045 DBMET00675 | DBMET00675 | |
| 0.032 | 0.021 | 0.032 | Cholesterol ester transfer protein antagonist | |||
| 0.092 | 0.083 | 0.092 | Folate antagonist | |||
| 0.062 | 0.053 | 0.062 | Alpha adrenoreceptor agonist | |||
| 0.056 | 0.048 | 0.056 | Alpha 2 adrenoreceptor agonist | |||
| 0.048 | 0.041 | 0.048 | H+/K+-transporting ATPase inhibitor | |||
| 0.051 | 0.044 | 0.056 | Heparanase inhibitor | 0.056 0.031 DBMET00675 | DBMET00675 | |
| 0.016 | 0.009 | 0.022 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.022 0.004 DBMET00675 | DBMET00675 | |
| 0.059 | 0.053 | 0.059 | Fibroblast growth factor 2 antagonist | |||
| 0.029 | 0.024 | 0.029 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.075 | 0.072 | 0.075 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.054 | 0.053 | 0.054 | CDK1/cyclin B inhibitor | |||
| 0.086 | 0.085 | 0.086 | Insulin receptor antagonist | |||
| 0.213 | 0.214 | 0.318 | Antibacterial | 0.318 0.122 DBMET00675 | DBMET00675 | |
| 0.047 | 0.049 | 0.075 | Protein kinase C eta inhibitor | 0.075 0.026 DBMET00675 | DBMET00675 | |
| 0.016 | 0.023 | 0.018 | Potassium channel (Inward rectifier) 11 blocker | 0.018 0.014 DBMET00675 | DBMET00675 | |
| 0.139 | 0.147 | 0.167 | Dyrk kinase inhibitor | 0.167 0.12 DBMET00675 | DBMET00675 | |
| 0.176 | 0.185 | 0.244 | Gastrin inhibitor | 0.244 0.086 DBMET00675 | DBMET00675 | |
| 0.03 | 0.039 | 0.036 | Protein kinase C beta I inhibitor | 0.036 0.016 DBMET00675 | DBMET00675 | |
| 0.007 | 0.022 | 0.017 | Imidazoline I2 receptor antagonist | 0.017 0.004 DBMET00675 | DBMET00675 | |
| 0.075 | 0.091 | 0.086 | Hematopoietic | 0.086 0.058 DBMET00675 | DBMET00675 | |
| 0.027 | 0.044 | 0.037 | Diamine oxidase inhibitor | 0.037 0.027 DBMET00675 | DBMET00675 | |
| 0.07 | 0.089 | 0.078 | MAP kinase 7 inhibitor | 0.078 0.052 DBMET00675 | DBMET00675 | |
| 0.086 | 0.11 | 0.124 | DOPA decarboxylase inhibitor | 0.124 0.04 DBMET00675 | DBMET00675 | |
| 0.149 | 0.175 | 0.197 | DNA damaging | 0.197 0.118 DBMET00675 | DBMET00675 | |
| 0.062 | 0.089 | 0.076 | Ornithine decarboxylase inhibitor | 0.076 0.072 DBMET00675 | DBMET00675 | |
| 0.229 | 0.259 | 0.339 | 5 Hydroxytryptamine release inhibitor | 0.339 0.125 DBMET00675 | DBMET00675 | |
| 0.026 | 0.058 | 0.04 | Urokinase inhibitor | 0.04 0.039 DBMET00675 | DBMET00675 | |
| 0.024 | 0.057 | 0.032 | Protein kinase C beta II inhibitor | 0.032 0.024 DBMET00675 | DBMET00675 | |
| 0.112 | 0.146 | 0.154 | GABA C receptor rho-2 antagonist | 0.154 0.069 DBMET00675 | DBMET00675 | |
| 0.048 | 0.082 | 0.077 | Cyclin B3 inhibitor | 0.077 0.04 DBMET00675 | DBMET00675 | |
| 0.016 | 0.051 | 0.037 | Nicotinic alpha4beta2 receptor agonist | 0.037 0.01 DBMET00675 | DBMET00675 | |
| 0.06 | 0.096 | 0.091 | Carbonic anhydrase VI inhibitor | 0.091 0.046 DBMET00675 | DBMET00675 | |
| 0.125 | 0.162 | 0.157 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.157 0.124 DBMET00675 | DBMET00675 | |
| 0.156 | 0.196 | 0.301 | Prostaglandin dehydrogenase inhibitor | 0.301 0.101 DBMET00675 | DBMET00675 | |
| 0.185 | 0.229 | 0.295 | 15-Lipoxygenase inhibitor | 0.295 0.135 DBMET00675 | DBMET00675 | |
| 0.044 | 0.102 | 0.079 | Protein kinase C beta inhibitor | 0.079 0.031 DBMET00675 | DBMET00675 | |
| 0.018 | 0.077 | 0.035 | Factor VIIa inhibitor | 0.035 0.03 DBMET00675 | DBMET00675 | |
| 0.131 | 0.191 | 0.196 | Cyclic AMP phosphodiesterase inhibitor | 0.196 0.097 DBMET00675 | DBMET00675 | |
| 0.07 | 0.13 | 0.674 | Nav1.1 sodium channel blocker | 0.674 0.003 DBMET00675 | DBMET00675 | |
| 0.053 | 0.114 | 0.085 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.085 0.028 DBMET00675 | DBMET00675 | |
| 0.072 | 0.137 | 0.172 | Amylase inhibitor | 0.172 0.054 DBMET00675 | DBMET00675 | |
| 0.072 | 0.139 | 0.269 | Nav1.4 sodium channel blocker | 0.269 0.005 DBMET00675 | DBMET00675 | |
| 0.144 | 0.216 | 0.221 | DNA synthesis inhibitor | 0.221 0.093 DBMET00675 | DBMET00675 | |
| 0.096 | 0.168 | 0.168 | Arachidonic acid antagonist | 0.168 0.068 DBMET00675 | DBMET00675 | |
| 0.065 | 0.141 | 0.098 | Adenylate cyclase inhibitor | 0.098 0.086 DBMET00675 | DBMET00675 | |
| 0.025 | 0.101 | 0.044 | Dihydrofolate reductase inhibitor | 0.044 0.029 DBMET00675 | DBMET00675 | |
| 0.082 | 0.164 | 0.182 | Peroxidase inhibitor | 0.182 0.065 DBMET00675 | DBMET00675 | |
| 0.07 | 0.158 | 0.125 | Adenylate kinase inhibitor | 0.125 0.039 DBMET00675 | DBMET00675 | |
| 0.012 | 0.105 | 0.039 | Potassium channel small-conductance Ca-activated activator | 0.039 0.016 DBMET00675 | DBMET00675 | |
| 0.146 | 0.24 | 0.201 | 5 Hydroxytryptamine 3E antagonist | 0.201 0.061 DBMET00675 | DBMET00675 | |
| 0.057 | 0.155 | 0.092 | NADH dehydrogenase inhibitor | 0.092 0.053 DBMET00675 | DBMET00675 | |
| 0.02 | 0.118 | 0.039 | Histamine H2 receptor agonist | 0.039 0.036 DBMET00675 | DBMET00675 | |
| 0.148 | 0.246 | 0.195 | Vasodilator, peripheral | 0.195 0.182 DBMET00675 | DBMET00675 | |
| 0.141 | 0.244 | 0.195 | Nitric-oxide synthase stimulant | 0.195 0.097 DBMET00675 | DBMET00675 | |
| 0.019 | 0.125 | 0.047 | Thymidylate synthase inhibitor | 0.047 0.032 DBMET00675 | DBMET00675 | |
| 0.103 | 0.214 | 0.138 | 3C-like protease (Human coronavirus) inhibitor | 0.138 0.125 DBMET00675 | DBMET00675 | |
| 0.113 | 0.226 | 0.241 | Streptokinase A inhibitor | 0.241 0.108 DBMET00675 | DBMET00675 | |
| 0.008 | 0.122 | 0.023 | Integrin beta5 antagonist | 0.023 0.012 DBMET00675 | DBMET00675 | |
| 0.04 | 0.156 | 0.103 | Potassium channel (Ca-activated) activator | 0.103 0.053 DBMET00675 | DBMET00675 | |
| 0.157 | 0.275 | 0.382 | GABA C receptor rho-3 antagonist | 0.382 0.07 DBMET00675 | DBMET00675 | |
| 0.026 | 0.144 | 0.077 | Aldosterone antagonist | 0.077 0.012 DBMET00675 | DBMET00675 | |
| 0.059 | 0.179 | 0.083 | MAP kinase kinase 1 inhibitor | 0.083 0.082 DBMET00675 | DBMET00675 | |
| 0.135 | 0.258 | 0.197 | Calpain 2 inhibitor | 0.197 0.19 DBMET00675 | DBMET00675 | |
| 0.058 | 0.186 | 0.082 | D-Ala-D-Ala ligase inhibitor | 0.082 0.062 DBMET00675 | DBMET00675 | |
| 0.155 | 0.285 | 0.327 | Interleukin 2 agonist | 0.327 0.057 DBMET00675 | DBMET00675 | |
| 0.119 | 0.25 | 0.277 | Superoxide dismutase inhibitor | 0.277 0.06 DBMET00675 | DBMET00675 | |
| 0.077 | 0.212 | 0.131 | Dual specificity phosphatase 3 inhibitor | 0.131 0.115 DBMET00675 | DBMET00675 | |
| 0.042 | 0.177 | 0.073 | Glycine receptor agonist | 0.073 0.049 DBMET00675 | DBMET00675 | |
| 0.045 | 0.182 | 0.098 | Chymotrypsin inhibitor | 0.098 0.037 DBMET00675 | DBMET00675 | |
| 0.135 | 0.276 | 0.218 | Antithrombotic | 0.218 0.156 DBMET00675 | DBMET00675 | |
| 0.079 | 0.22 | 0.141 | Mannose-6-phosphate isomerase inhibitor | 0.141 0.073 DBMET00675 | DBMET00675 | |
| 0.163 | 0.304 | 0.199 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.199 0.168 DBMET00675 | DBMET00675 | |
| 0.052 | 0.198 | 0.093 | GABA C receptor rho-1 antagonist | 0.093 0.073 DBMET00675 | DBMET00675 | |
| 0.105 | 0.257 | 0.15 | Death-associated protein kinase 2 inhibitor | 0.15 0.105 DBMET00675 | DBMET00675 | |
| 0.046 | 0.199 | 0.16 | Ferrochelatase inhibitor | 0.16 0.034 DBMET00675 | DBMET00675 | |
| 0.012 | 0.167 | 0.09 | NMDA 2A receptor antagonist | 0.09 0.016 DBMET00675 | DBMET00675 | |
| 0.035 | 0.195 | 0.101 | Secretase beta inhibitor | 0.101 0.018 DBMET00675 | DBMET00675 | |
| 0.035 | 0.199 | 0.098 | Histamine N-methyltransferase inhibitor | 0.098 0.048 DBMET00675 | DBMET00675 | |
| 0.029 | 0.193 | 0.104 | Cathepsin G inhibitor | 0.104 0.032 DBMET00675 | DBMET00675 | |
| 0.029 | 0.193 | 0.053 | Dihydroorotate oxidase inhibitor | 0.053 0.043 DBMET00675 | DBMET00675 | |
| 0.02 | 0.185 | 0.056 | Biliverdin reductase inhibitor | 0.056 0.045 DBMET00675 | DBMET00675 | |
| 0.029 | 0.194 | 0.084 | Phospholipase D inhibitor | 0.084 0.029 DBMET00675 | DBMET00675 | |
| 0.018 | 0.184 | 0.046 | Histamine H1 receptor agonist | 0.046 0.025 DBMET00675 | DBMET00675 | |
| 0.126 | 0.293 | 0.248 | Alpha-glucosidase inhibitor | 0.248 0.189 DBMET00675 | DBMET00675 | |
| 0.136 | 0.303 | 0.249 | Tyrosine 3 hydroxylase inhibitor | 0.249 0.069 DBMET00675 | DBMET00675 | |
| 0.048 | 0.217 | 0.094 | Protein kinase C zeta inhibitor | 0.094 0.059 DBMET00675 | DBMET00675 | |
| 0.046 | 0.216 | 0.07 | MDM2 inhibitor | 0.07 0.038 DBMET00675 | DBMET00675 | |
| 0.108 | 0.28 | 0.141 | Ca2+-transporting ATPase inhibitor | 0.141 0.068 DBMET00675 | DBMET00675 | |
| 0.043 | 0.218 | 0.141 | GABA C receptor agonist | 0.141 0.038 DBMET00675 | DBMET00675 | |
| 0.063 | 0.239 | 0.221 | Anticoagulant | 0.221 0.046 DBMET00675 | DBMET00675 | |
| 0.028 | 0.207 | 0.118 | MAO A inhibitor | 0.118 0.053 DBMET00675 | DBMET00675 | |
| 0.052 | 0.234 | 0.145 | Alpha-N-acetylglucosaminidase inhibitor | 0.145 0.058 DBMET00675 | DBMET00675 | |
| 0.049 | 0.234 | 0.092 | Electrolyte absorption antagonist | 0.092 0.07 DBMET00675 | DBMET00675 | |
| 0.064 | 0.256 | 0.211 | Diuretic | 0.211 0.04 DBMET00675 | DBMET00675 | |
| 0.042 | 0.235 | 0.127 | 5 Hydroxytryptamine 3A agonist | 0.127 0.05 DBMET00675 | DBMET00675 | |
| 0.121 | 0.315 | 0.216 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.216 0.14 DBMET00675 | DBMET00675 | |
| 0.02 | 0.216 | 0.046 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.046 0.02 DBMET00675 | DBMET00675 | |
| 0.068 | 0.265 | 0.151 | Thiol protease inhibitor | 0.151 0.067 DBMET00675 | DBMET00675 | |
| 0.043 | 0.242 | 0.08 | Triose-phosphate isomerase inhibitor | 0.08 0.076 DBMET00675 | DBMET00675 | |
| 0.011 | 0.215 | 0.096 | NMDA 2 receptor antagonist | 0.096 0.034 DBMET00675 | DBMET00675 | |
| 0.02 | 0.231 | 0.06 | Phenylalanine 4-hydroxylase inhibitor | 0.06 0.058 DBMET00675 | DBMET00675 | |
| 0.137 | 0.348 | 0.223 | 5 Hydroxytryptamine uptake stimulant | 0.223 0.113 DBMET00675 | DBMET00675 | |
| 0.029 | 0.246 | 0.108 | MAO inhibitor | 0.108 0.083 DBMET00675 | DBMET00675 | |
| 0.052 | 0.27 | 0.177 | Nav1.5 sodium channel blocker | 0.177 0.017 DBMET00675 | DBMET00675 | |
| 0.014 | 0.241 | 0.058 | Argininosuccinate synthase inhibitor | 0.058 0.039 DBMET00675 | DBMET00675 | |
| 0.036 | 0.267 | 0.099 | UDP-glucose 4-epimerase inhibitor | 0.099 0.062 DBMET00675 | DBMET00675 | |
| 0.043 | 0.275 | 0.127 | Beta amyloid protein antagonist | 0.127 0.06 DBMET00675 | DBMET00675 | |
| 0.033 | 0.264 | 0.125 | Glycogen synthase kinase-3 alpha inhibitor | 0.125 0.081 DBMET00675 | DBMET00675 | |
| 0.06 | 0.296 | 0.145 | Anticonvulsant | 0.145 0.135 DBMET00675 | DBMET00675 | |
| 0.018 | 0.257 | 0.076 | Nicotinic alpha4beta2 receptor antagonist | 0.076 0.054 DBMET00675 | DBMET00675 | |
| 0.027 | 0.268 | 0.09 | Alcohol dehydrogenase inhibitor | 0.09 0.064 DBMET00675 | DBMET00675 | |
| 0.088 | 0.331 | 0.184 | 12-Lipoxygenase inhibitor | 0.184 0.169 DBMET00675 | DBMET00675 | |
| 0.038 | 0.283 | 0.085 | GABA B receptor agonist | 0.085 0.033 DBMET00675 | DBMET00675 | |
| 0.021 | 0.267 | 0.105 | NMDA receptor antagonist | 0.105 0.044 DBMET00675 | DBMET00675 | |
| 0.072 | 0.331 | 0.144 | Succinate dehydrogenase inhibitor | 0.144 0.123 DBMET00675 | DBMET00675 | |
| 0.023 | 0.289 | 0.185 | Inducible nitric-oxide synthase inhibitor | 0.185 0.01 DBMET00675 | DBMET00675 | |
| 0.031 | 0.299 | 0.096 | Cystathionine beta-synthase inhibitor | 0.096 0.081 DBMET00675 | DBMET00675 | |
| 0.038 | 0.308 | 0.275 | Psychostimulant | 0.275 0.05 DBMET00675 | DBMET00675 | |
| 0.036 | 0.309 | 0.082 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.082 0.077 DBMET00675 | DBMET00675 | |
| 0.028 | 0.302 | 0.115 | Glutamate receptor antagonist | 0.115 0.08 DBMET00675 | DBMET00675 | |
| 0.038 | 0.317 | 0.061 | Calcium channel P-type blocker | 0.061 0.054 DBMET00675 | DBMET00675 | |
| 0.056 | 0.339 | 0.248 | Interleukin agonist | 0.248 0.08 DBMET00675 | DBMET00675 | |
| 0.034 | 0.331 | 0.148 | Sodium channel blocker | 0.148 0.06 DBMET00675 | DBMET00675 | |
| 0.026 | 0.349 | 0.171 | Nitric-oxide synthase inhibitor | 0.171 0.016 DBMET00675 | DBMET00675 | |
| 0.081 | 0.404 | 0.154 | Neurotensin receptor agonist | 0.154 0.092 DBMET00675 | DBMET00675 | |
| 0.031 | 0.362 | 0.156 | Nav1.6 sodium channel blocker | 0.156 0.047 DBMET00675 | DBMET00675 | |
| 0.083 | 0.414 | 0.187 | 5 Hydroxytryptamine release stimulant | 0.187 0.133 DBMET00675 | DBMET00675 | |
| 0.024 | 0.383 | 0.145 | Sodium channel (voltage-gated) blocker | 0.145 0.058 DBMET00675 | DBMET00675 | |
| 0.024 | 0.391 | 0.059 | Trypsin inhibitor | 0.059 0.05 DBMET00675 | DBMET00675 | |
| 0.037 | 0.418 | 0.219 | Nav1.2 sodium channel blocker | 0.219 0.028 DBMET00675 | DBMET00675 | |
| 0.024 | 0.41 | 0.067 | Cathepsin E inhibitor | 0.067 0.032 DBMET00675 | DBMET00675 | |
| 0.004 | 0.411 | 0.058 | Protease activated receptor 1 antagonist | 0.058 0.028 DBMET00675 | DBMET00675 | |
| 0.029 | 0.464 | 0.13 | Cell wall synthesis inhibitor | 0.13 0.086 DBMET00675 | DBMET00675 | |
| 0.009 | 0.86 | 0.127 | Insulin secretagoues | 0.127 0.101 DBMET00675 | DBMET00675 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |